Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study

MLA

Vincent Pernin, Md, PhD, et al. “Long-Term Prolonged-Release Tacrolimus-Based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study.” Transplantation Direct, vol. 9, no. 3, Mar. 2023, p. e1432. EBSCOhost, https://doi.org/10.1097/TXD.0000000000001432.

APA

Vincent Pernin, M., PhD, Maciej Glyda, M., PhD, Ondrej Viklický, M., PhD, Aleksander Lõhmus, M., Lars Wennberg, M., PhD, Oliver Witzke, M., Bengt von Zur-Mühlen, M., PhD, Swapneel Anaokar, M., Martin Hurst, F., Gbenga Kazeem, P., Nasrullah Undre, P., & Dirk R.J. Kuypers, M., PhD. (2023). Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study. Transplantation Direct, 9(3), e1432. https://doi.org/10.1097/TXD.0000000000001432

Chicago

Vincent Pernin, Md, PhD, Md Maciej Glyda PhD, Md Ondrej Viklický PhD, Md Aleksander Lõhmus, Md Lars Wennberg PhD, Md Oliver Witzke, Md Bengt von Zur-Mühlen PhD, et al. 2023. “Long-Term Prolonged-Release Tacrolimus-Based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study.” Transplantation Direct 9 (3): e1432. doi:10.1097/TXD.0000000000001432.